DermaRep™ Device in the Treatment of Venous Leg Ulcers

Inclusion Criteria: * The patient is at least 18 years of age * The patient is male and female not pregnant or lactating and using contraception * The patient has a confirmed venous leg ulcer with:Confirmed actively managed reflux; No exposed tendon or bone; Ulcer surface area between 2cm2 and 80cm; ABPI\>0.8 * The patient agrees to abstain from enrolment in any other clinical trial for the duration of the study * The patient is able to understand the aims and objectives of the trial and is willing to consent Exclusion Criteria: * Study treatment area has exposed bone or tendon * Poorly controlled diabetes * Arterial insufficiency (ABPI\<0.8) * Pregnant/lactating females (tested as per institutional requirements) * The patient has a severe dermatological disorder (e.g. severe psoriasis, epidermolysis bullosa, pyoderma granulosum) * The patient is unable to follow the procedures set by the protocol * The patient has a history of any significant cardiac, pulmonary, renal. hepatic, neurological and/or immune dysfunction that in the opinion of the investigator may compromise patient safety or study objectives * The patient is taking any known medications that in the opinion of the investigator may compromise patient safety or the study objectives * The patient has any known allergies to any of the device materials to be used in the trial (egg allergy) * The patient is a vulnerable or protected adult * The patient is unable to provide consent